Jacob Steven Leach, DexCom, Inc.'s President and CEO who will summarize our recent highlights and ongoing strategic initiatives. Followed by a financial review and outlook from Jereme M. Sylvain, our ...

DexCom (NASDAQ:DXCM) is gearing up to announce its quarterly earnings on Thursday, 2026-02-12. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

People have been riding the GLP-1 wave to achieve quick and significant weight loss. But given the drug’s effect on controlling type 2 diabetes, it’s no surprise that DexCom CEO Jake Leach wants to ...

Investing.com -- Barclays downgraded DexCom and Insulet, two large-cap diabetes device makers, to Underweight as it expects rising competition in 2026 and 2027 to weigh on valuation multiples and ...

DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last closing at $66.54 after mixed short term and ...

In this video, we will about training word embeddings by writing a python code. So we will write a python code to train word embeddings. To train word embeddings, we need to solve a fake problem. This ...

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter net income of $283.8 million. The San Diego-based company said it had net income of 70 cents per share. Earnings ...

Dexcom expects to lay off 319 employees in San Diego, CA, according to a Worker Adjustment and Retraining Notification (WARN) notice filed Aug. 27. The workforce reduction is set to go into effect Nov ...

Dexcom, the company that specializes in continuous glucose monitoring systems, announced Wednesday that it would be laying off 3% of its workforce. (Cheng Xin/Getty Images) Dexcom, a ...

All-star teams gather together the best athletes in their respective sports, but one college all-star team has the unique distinction of bringing together top-notch athletes all united by diabetes.

After taking on the title of president earlier this year, Dexcom’s Jake Leach will be stepping into the role of CEO at the start of 2026, succeeding Kevin Sayer, who will step down after a decade of ...

July 30 (Reuters) - Dexcom (DXCM.O), opens new tab beat estimates for second-quarter results on Wednesday, driven by strong demand for its continuous glucose monitors, and named Jake Leach as its CEO.